Market Overview

15 Biggest Mid-Day Losers For Monday

Share:
  • Vince Holding Corp (NYSE: VNCE) shares dipped 25 percent to $0.975. Vince reported a delay in fiscal 2016 10-K filing.
  • Skyline Corporation (NYSE: SKY) shares tumbled 23.8 percent to $6.44. Skyline posted a Q3 net loss of $2,447,000, or $0.29 per share, versus year-ago net loss of $520,000 or $0.06 per share.
  • Oncomed Pharmaceuticals Inc (NASDAQ: OMED) shares dropped 18.7 percent to $3.88 as the company disclosed that its Phase 2 trial of tarextumab did not meet endpoints. OncoMed also reported that it will discontinue enrollment in Phase 1B clinical trial of brontictuzumab.
  • Snyder's-Lance Inc (NASDAQ: LNCE) shares fell 18.5 percent to $32.55. Snyder's-Lance announced the retirement of its CEO and issued a weak forecast.
  • Immune Pharmaceuticals Inc (NASDAQ: IMNP) shares dropped 11.8 percent to $2.25 after declining 2.67 percent on Thursday.
  • Apricus Biosciences Inc (NASDAQ: APRI) shares dropped 11.3 percent to $1.72. Apricus Biosciences filed for offering of up to $6 million of units.
  • China Auto Logistics Inc (NASDAQ: CALI) shares fell 11.1 percent to $2.66.
  • Incyte Corporation (NASDAQ: INCY) dropped 11 percent to $125.34. The FDA on Friday declined to approve Eli Lilly and Co and Incyte arthritis drug Olumiant. PiperJaffray downgraded Incyte from Overweight to Neutral.
  • Timkensteel Corp (NYSE: TMST) declined 10.9 percent to $15.77. TimkenSteel projects Q1 net sales of around $309 million on 280,000 ship tons and a net loss of around $5 million.
  • Biostar Pharmaceuticals Inc (NASDAQ: BSPM) shares dropped 10.8 percent to $2.03. Biostar Pharmaceuticals reported a FY16 net loss of $5.7 million on sales of $2.4 million.
  • Adeptus Health Inc (NYSE: ADPT) shares declined 9.8 percent to $2.11.
  • Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) fell 9.6 percent to $14.48. Chardan Capital reiterated Akari Therapeutics with a Sell and raised the price target from $5.00 to $6.50.
  • GWG Holdings Inc (NASDAQ: GWGH) shares declined 9 percent to $9.60 after dropping 5.62 percent on Thursday.
  • SemiLEDs Corporation (NASDAQ: LEDS) shares dropped 8.6 percent to $2.87.
  • Eli Lilly and Co (NYSE: LLY) fell 4.1 percent to $82.39. The FDA on Friday declined to approve Eli Lilly and Incyte arthritis drug Olumiant. BMO Capital downgraded Eli Lilly from Market Perform to Underperform.

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets Analyst Ratings

 

Related Articles (ADPT + AKTX)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
BBBYKeyBancUpgrades18.0
ACMKeyBancMaintains48.0
NVSTWilliam BlairInitiates Coverage On
WENMorgan StanleyMaintains22.0
JAZZBernsteinReinstates150.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Hot Leveraged Sector ETFs

Snyder's-Lance CEO Change, Lower Guidance Leaves Bad Taste